Optical Coherence Tomography Comparative Study

NCT00069199 | Completed

• 2 other identifiers: 03029403-EI-0294
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

This study, conducted at the NIH Clinical Center and the University of Wisconsin University, will compare measurements obtained using older and newer models of a machine called an optical coherence tomography (OCT) scanner. This instrument uses a beam of light to measure the thickness of the retina, the light-sensitive inner lining of the back of the eye. OCT measurements will be done in multicenter clinical trials of new treatments for disorders that cause vision loss, such as macular edema. Because some centers in these studies will use the older OCT model and some the newer one, it is necessary to determine whether the two models give comparable results. People 18 years of age and older in the following categories may be eligible for this study:

• People with diabetes, with or without macular edema;
• People with other retinal disease, such as uveitis or vein occlusion in the retina;
• People with no history of eye disease who have a normal retina. Participants will have the following tests and procedures:
• Eye examination to assess vision and eye pressure and to evaluate the retina. The pupils are dilated with drops for this examination.
• Stereoscopic color fundus photography to examine the back of the eye. Eye drops are used to enlarge the size of the pupils to allow for a through examination and photographs of the eye using a special camera that flashes a bright light into the eye.
• OCT to measure retinal thickness. For this procedure, the subject sits in front of a small screen and looks at a target in the center of the screen while a dim red light moves across the subject's retina. This test is done first with one model of the OCT scanner, then the other. Finally, the test is repeated in both eyes with whichever model was used first. Patients who are being treated for macular edema will repeat the same tests at their 3-month visits.

Conditions

Retinal Disease; Healthy

Keywords

Reproducibility; Macular Edema; OCT2; OCT3; Retina

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient must understand and sign the informed consent.
• Patient must be at least 18 years of age.
• Pupillary dilation to at least 6 mm must be possible.
• Ocular media must be sufficiently clear to allow for quality images.

You may not qualify if:

• \. Any condition such as corneal opacifiation that precludes adequate slit lamp examination and photography of the fundus.

Sponsors & Collaborators

• National Eye Institute (NEI): lead

Study Sites (1)

National Eye Institute (NEI)

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

• Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998 Feb;105(2):360-70. doi: 10.1016/s0161-6420(98)93601-6.

  PMID: 9479300 BACKGROUND

• Strom C, Sander B, Larsen N, Larsen M, Lund-Andersen H. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):241-5.

  PMID: 11773037 BACKGROUND

• Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999 Jun;127(6):688-93. doi: 10.1016/s0002-9394(99)00033-1.

  PMID: 10372879 BACKGROUND

MeSH Terms

Conditions

Retinal Diseases; Macular Edema

Condition Hierarchy (Ancestors)

Eye Diseases; Macular Degeneration; Retinal Degeneration

Study Design

• Study Type: observational
• Sponsor Type: NIH

Study Record Dates

• First Submitted: September 17, 2003
• First Posted: September 18, 2003
• Study Start: September 1, 2003
• Study Completion: August 1, 2005
• Last Updated: March 4, 2008

Record last verified: 2005-08

Locations

US (1)